UBS Group Cuts Colgate-Palmolive (NYSE:CL) Price Target to $100.00

Colgate-Palmolive (NYSE:CL) had its price target reduced by UBS Group from $104.00 to $100.00 in a report published on Monday,Benzinga reports. They currently have a buy rating on the stock.

Several other research analysts have also issued reports on the stock. Piper Sandler cut their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. JPMorgan Chase & Co. cut their price target on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a report on Thursday, January 16th. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $101.16.

Colgate-Palmolive Stock Up 0.2 %

Shares of CL opened at $86.66 on Monday. Colgate-Palmolive has a 12 month low of $82.68 and a 12 month high of $109.30. The stock’s 50-day moving average price is $90.98 and its two-hundred day moving average price is $96.99. The company has a market capitalization of $70.80 billion, a PE ratio of 24.62, a PEG ratio of 3.61 and a beta of 0.44. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the firm posted $0.87 earnings per share. On average, analysts anticipate that Colgate-Palmolive will post 3.74 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.31%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 56.82%.

Institutional Trading of Colgate-Palmolive

A number of hedge funds have recently bought and sold shares of CL. FMR LLC lifted its holdings in Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after purchasing an additional 2,674,807 shares during the last quarter. Barclays PLC raised its position in shares of Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after purchasing an additional 2,132,747 shares during the period. State Street Corp lifted its stake in shares of Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after buying an additional 1,784,411 shares in the last quarter. Nordea Investment Management AB boosted its holdings in Colgate-Palmolive by 32.5% in the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock worth $462,121,000 after buying an additional 1,247,731 shares during the period. Finally, AustralianSuper Pty Ltd grew its stake in Colgate-Palmolive by 941.9% in the 4th quarter. AustralianSuper Pty Ltd now owns 1,138,655 shares of the company’s stock valued at $103,515,000 after buying an additional 1,029,364 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.